Viral micrornas encoded by nucleocapsid gene of sars‐cov‐2 are detected during infection, and targeting metabolic pathways in host cells

Abstract

MicroRNAs (miRNAs) are critical regulators of gene expression that may be used to iden-tify the pathological pathways influenced by disease and cellular interactions. Viral miRNAs (v-miRNAs) encoded by both DNA and RNA viruses induce immune dysregulation, virus production, and disease pathogenesis. Given the absence of effective treatment and the prevalence of highly infective SARS‐CoV‐2 strains, improved understanding of viral‐associated miRNAs could provide novel mechanistic insights into the pathogenesis of COVID‐19. In this study, SARS‐CoV‐2 v‐miR‐ NAs were identified by deep sequencing in infected Calu‐3 and Vero E6 cell lines. Among the ~0.1% small RNA sequences mapped to the SARS‐CoV‐2 genome, the top ten SARS‐CoV‐2 v‐miRNAs (including three encoded by the N gene; v‐miRNA‐N) were selected. After initial screening of con-served v‐miRNA‐N‐28612, which was identified in both SARS‐CoV and SARS‐CoV‐2, its expression was shown to be positively associated with viral load in COVID‐19 patients. Further in silico analysis and synthetic‐mimic transfection of validated SARS‐CoV‐2 v‐miRNAs revealed novel functional targets and associations with mechanisms of cellular metabolism and biosynthesis. Our findings support the development of v‐miRNA‐based biomarkers and therapeutic strategies based on improved understanding of the pathophysiology of COVID‐19.